The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSENS.L Regulatory News (SENS)

  • There is currently no data for SENS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holdings in Company

12 Apr 2022 07:00

RNS Number : 0348I
Sensyne Health PLC
12 April 2022
 

TR-1: Standard form for notification of major holdings

1. Issuer Details

ISIN

GB00BYV3J755

Issuer Name

SENSYNE HEALTH PLC

UK or Non-UK Issuer

UK

2. Reason for Notification

An acquisition or disposal of voting rights

3. Details of person subject to the notification obligation

Name

Baillie Gifford & Co

City of registered office (if applicable)

Edinburgh

Country of registered office (if applicable)

United Kingdom

4. Details of the shareholder

Full name of shareholder(s) if different from the person(s) subject to the notification obligation, above

 

City of registered office (if applicable)

 

Country of registered office (if applicable)

 

5. Date on which the threshold was crossed or reached

08-Apr-2022

6. Date on which Issuer notified

11-Apr-2022

7. Total positions of person(s) subject to the notification obligation

 

% of voting rights attached to shares (total of 8.A)

% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights held in issuer

Resulting situation on the date on which threshold was crossed or reached

0.000000

0.000000

0.000000

0

Position of previous notification (if applicable)

 

 

 

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

8A. Voting rights attached to shares

Class/Type of shares ISIN code(if possible)

Number of direct voting rights (DTR5.1)

Number of indirect voting rights (DTR5.2.1)

% of direct voting rights (DTR5.1)

% of indirect voting rights (DTR5.2.1)

GB00BYV3J755

 

0

 

0.000000

Sub Total 8.A

0

0.000000%

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

Type of financial instrument

Expiration date

Exercise/conversion period

Number of voting rights that may be acquired if the instrument is exercised/converted

% of voting rights

 

 

 

 

 

Sub Total 8.B1

 

 

 

8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))

Type of financial instrument

Expiration date

Exercise/conversion period

Physical or cash settlement

Number of voting rights

% of voting rights

 

 

 

 

 

 

Sub Total 8.B2

 

 

 

9. Information in relation to the person subject to the notification obligation

2. Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entities (please add additional rows as necessary)

Ultimate controlling person

Name of controlled undertaking

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

Baillie Gifford & Co

 

 

 

 

10. In case of proxy voting

Name of the proxy holder

 

The number and % of voting rights held

 

The date until which the voting rights will be held

 

11. Additional Information

 

12. Date of Completion

11 April 2022

13. Place Of Completion

Edinburgh

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLKZGMDLMZGZZM
Date   Source Headline
5th Feb 20217:00 amRNSManagement appointments
3rd Feb 20217:00 amRNSLaunch of AI algorithm for patient management
21st Jan 20217:00 amRNSSensyne Health Interim Results
20th Jan 20217:00 amRNSSensyne signs SRA with Wolverhampton NHS Trust
19th Jan 202111:06 amRNSHolding(s) in Company
15th Jan 20214:41 pmRNSSecond Price Monitoring Extn
15th Jan 20214:36 pmRNSPrice Monitoring Extension
14th Jan 20217:00 amRNSSensyne launches MagnifEye smartphone app
13th Jan 20212:58 pmRNSHolding(s) in Company
11th Jan 20217:00 amRNSNotice of Interim Results
7th Jan 20215:12 pmRNSHolding(s) in Company
7th Jan 20215:09 pmRNSHolding(s) in Company
4th Jan 20213:06 pmRNSResult of General Meeting & Fundraising Completion
4th Jan 20213:05 pmRNSResult of Open Offer
18th Dec 20207:00 amRNSSensyne Health appoints Non-Executive Director
15th Dec 20207:00 amRNSLaunch of First Digital Health Product in the US
14th Dec 20207:00 amRNSPublication of Circular and General Meeting Notice
9th Dec 202011:06 amRNSSecond Price Monitoring Extn
9th Dec 202011:01 amRNSPrice Monitoring Extension
9th Dec 20209:05 amRNSSecond Price Monitoring Extn
9th Dec 20209:00 amRNSPrice Monitoring Extension
9th Dec 20207:00 amRNSSuccessful completion of Fundraise
8th Dec 20205:36 pmRNSProposed Fundraising
25th Nov 20207:00 amRNSSensyne Health Agreement with Hampshire NHS Trust
17th Nov 20202:05 pmRNSSecond Price Monitoring Extn
17th Nov 20202:00 pmRNSPrice Monitoring Extension
16th Nov 20207:02 amRNSSensyne Health achieves 5 million patient target
16th Nov 20207:00 amRNSSensyne Health Agreement with Somerset NHS Trust
13th Nov 20207:00 amRNSSensyne Health appoints President, North America
2nd Nov 20207:00 amRNSCOVID-19 testing study at University of Oxford
30th Oct 20204:33 pmRNSResult of AGM
28th Oct 20207:00 amRNSSensyne Health Agreement with Microsoft
26th Oct 20207:00 amRNSSensyne Health Agreement with Milton Keynes UH
23rd Oct 20207:00 amRNSSensyne Health agreement with Bristol Myers Squibb
6th Oct 20207:00 amRNSAnnual Report and Accounts and Notice of AGM
5th Oct 20204:40 pmRNSSecond Price Monitoring Extn
5th Oct 20204:35 pmRNSPrice Monitoring Extension
1st Oct 20206:07 pmRNSHolding(s) in Company
1st Oct 20202:00 pmRNSAgreement with NHS Greater Glasgow and Clyde
30th Sep 20201:12 pmRNSCollaboration with the University of Oxford
30th Sep 20207:01 amRNSSensyne Health Long Term Incentive Plan
30th Sep 20207:00 amRNSSensyne Health Full Year Results
29th Sep 202011:55 amRNSHolding(s) in Company
29th Sep 20209:46 amRNSHolding(s) in Company
23rd Sep 20207:00 amRNSNotice of Full Year Results
10th Sep 20207:00 amRNSSensyne Health appoints Chief Operating Officer
3rd Sep 20207:00 amRNSUK launch of ‘SENSE’ in partnership with Microsoft
20th Aug 20209:05 amRNSSecond Price Monitoring Extn
20th Aug 20209:00 amRNSPrice Monitoring Extension
19th Aug 20202:05 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.